Literature DB >> 32380231

Multidisciplinary treatment for hilar and intrahepatic cholangiocarcinoma: A review of the general principles.

Gonzalo Sapisochin1, Tommy Ivanics1, Vijay Subramanian2, Majella Doyle3, Julie K Heimbach4, Johnny C Hong5.   

Abstract

Cholangiocarcinoma (CCA) is a rare but devastating malignancy that presents late, and associated with a high mortality if untreated. CCA is locally aggressive and located in close proximity to vital structures i.e. the portal vein and hepatic artery. A complete extirpation of the tumor including microscopically detectable disease R0 resection offers the best possibility of long-term survival in patients with CCA. As such, the surgical approach to achieve a R0 resection is dictated by the location of the tumor and the presence of underlying liver disease. The present article focuses on the general principles of the multidisciplinary treatment of hilar and intrahepatic CCA.
Copyright © 2020 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hepatic resection; Hilar cholangiocarcinoma; Intrahepatic cholangiocarcinoma; Neoadjuvant therapy; Orthotopic liver transplantation

Mesh:

Year:  2020        PMID: 32380231     DOI: 10.1016/j.ijsu.2020.04.067

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  8 in total

1.  Risk factors of delayed recovery from general anesthesia in patients undergoing radical biliary surgery: What can we prevent.

Authors:  Guohui Zhang; Bingbing Pan; Dan Tan; Yingzi Ling
Journal:  Medicine (Baltimore)       Date:  2021-08-13       Impact factor: 1.817

2.  Improving Outcomes in Perihilar Cholangiocarcinoma.

Authors:  Karl J Oldhafer; Thomas von Hahn; Marianna Arvanitakis; Masato Nagino; Orlando J M Torres
Journal:  Visc Med       Date:  2021-01-06

Review 3.  Endoscopic or percutaneous biliary drainage in hilar cholangiocarcinoma: When and how?

Authors:  Tudor Mocan; Adelina Horhat; Emil Mois; Florin Graur; Cristian Tefas; Rares Craciun; Iuliana Nenu; Mihaela Spârchez; Zeno Sparchez
Journal:  World J Gastrointest Oncol       Date:  2021-12-15

4.  Incidence Trend and Competing Risk Analysis of Patients With Intrahepatic Cholangiocarcinoma: A Population-Based Study.

Authors:  Huiwu Xing; Bingqian Tan; Chenyu Yang; Mingman Zhang
Journal:  Front Med (Lausanne)       Date:  2022-03-30

5.  Effectiveness of Trastuzumab Combined With Capecitabine Treatment in a Patient With Hilar Cholangiocarcinoma Complicated by Liver Metastases With an ERBB2-Activating Mutation: A Case Report.

Authors:  Daobing Zeng; Xiaofei Zhao; Liang Di; Luyan Lou; Yanfang Song; Yanrui Zhang; Huanhuan Liu; Guangming Li
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

6.  Chemokine (C-C motif) ligand 18/membrane-associated 3/forkhead box O1 axis promotes the proliferation, migration, and invasion of intrahepatic cholangiocarcinoma.

Authors:  Chusi Wang; Hao Liang; Yanjie Li; Zhaofeng Tang; Yingcai Zhang
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 7.  Effects of portal vein resection and hepatic artery resection on long-term survival in Klatskin tumor: a meta-analysis.

Authors:  Yun Song; Yujie Zhang; Zhijie Zhen; Zhaohui Huang
Journal:  World J Surg Oncol       Date:  2022-07-12       Impact factor: 3.253

8.  Liver transplantation and hepatobiliary surgery in 2020.

Authors:  Burcin Ekser; Karim J Halazun; Henrik Petrowsky; Deniz Balci
Journal:  Int J Surg       Date:  2020-07-19       Impact factor: 13.400

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.